Found 20 clinical trials
Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients
tumor's HER2 is positive, the patient can receive targeted therapy (Herceptin) combined with tamoxifen or placebo. The follow-up time will be eight years. The aim of this trial is to evaluate the
- 30 views
- 18 May, 2022
- 17 locations
Pre Operative Trastuzumab in Operable Breast Cancer
single dose of Trastuzumab (Herceptin, Hoffman La Roche) at 8 mg/Kg as a 90 minute intravenous infusion in 250 ml of normal saline, in the window period of 10-15 4 to 14 days (both days inclusive) prior
- 71 views
- 14 May, 2022
- 1 location
Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast Cancer
positive HER-2, additional Herceptin could improve the response further. In this study the efficacy of combined neoadjuvant therapy with or without Herceptin should be evaluated and the role in predicting
- 7 views
- 21 Jan, 2021
- 2 locations
Detect V / CHEVENDO (Chemo vs. Endo)
Chemo- versus endocrine therapy in combination with dual HER2-targeted therapy of Herceptin® (trastuzumab) and Perjeta® (pertuzumab) plus Kisqali® (ribociclib) in patients with HER2 positive and
- 35 views
- 08 Aug, 2022
- 1 location
GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases
>Trastuzumab (Herceptin®)
- 2 views
- 16 Mar, 2022
The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer
This research study is studying a combination of drugs as a possible treatment for breast cancer. The drugs involved in this study are: Group A: Trastuzumab (Herceptin
- 30 views
- 21 Jul, 2022
- 16 locations
MARGetuximab Or Trastuzumab (MARGOT) (MARGOT)
. Drugs and Combinations used: Paclitaxel, Pertzumab and Margetuximab (Margenza) Paclitaxel, Pertzumab and Trastuzumab (Herceptin)
- 19 views
- 13 Jul, 2022
- 15 locations
ATEMPT 2.0: Adjuvant T-DM1 vs TH
therapies as a treatment after surgery. The name of the study drugs involved are: Trastuzumab-emtansine (T-DM1, Kadcyla) Trastuzumab SC (Herceptin Hylecta)
- 1 views
- 10 Jul, 2022
- 17 locations
Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI
The purpose of the study is to see if using an investigational drug called [18F]FMISO with PET/MRI imaging can help monitor and predict the effect of trastuzumab (Herceptin) on chemotherapy in
- 0 views
- 23 Mar, 2022
- 1 location
A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020
of their activity based on antibody-dependent cell-mediated cytotoxicity (ADCC), mediated by natural killer (NK) cells. Trastuzumab (Herceptin®) is a recombinant DNA-derived humanized
- 0 views
- 15 Jun, 2022
- 1 location
- 1
- 2